ViewPoint Therapeutics

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. BMS Calls On SyntheX, Autolus In Protei

When asked if it's true that venture capital investors are no longer interested in funding very early-stage life science companies, Venrock Partner Camille Samuels told Biocom's recent Global Life Sci

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharma

IN VITRO DIAGNOSTICS ACT Genomics Co. Ltd. ACT Genomics closes $12.5mm Series B round ACT Genomics Co. Ltd. (molecular diagnostics and precision cancer care) raised $12.5mm through its Series